Table 2 Estimates of 5- and 10-year... | American Society of Hematology

Table 2

Estimates of 5- and 10-year relative survival of patients with ALL by age groups, sex, and calendar period

Relative survival by patient group (age or sex)	1980–1984		2000–2004		Increase*	P†
Relative survival by patient group (age or sex)	PE	SE	PE	SE	Increase*	P†
5-year
All	21.5	2.0	33.2	1.8	+11.7	< .001
15–19	41.0	4.9	61.1	4.4	+20.1	.001
20–29	25.1	4.8	44.8	4.7	+19.7	.003
30–44	20.2	4.8	34.3	3.9	+14.1	.002
45–59	10.3	4.9	24.3	3.4	+14.0	.001
≥ 60	8.4	3.4	12.7	2.9	+4.3	.48
Male	23.1	2.6	31.9	2.3	+8.8	< .001
Female	19.1	3.2	35.3	2.8	+16.2	.001
10-year
All	17.4	2.3	29.9	1.8	+12.5	< .001
15–19	33.0	4.9	60.4	4.4	+27.4	< .001
20–29	25.1	4.8	38.0	4.5	+12.9	.005
30–44	13.0	5.1	31.7	4.0	+18.7	< .001
45–59	8.4	4.4	20.2	3.4	+11.8	.001
≥ 60	5.1	3.9	9.3	2.8	+4.2	.49
Male	18.3	3.2	29.3	2.3	+11.0	< .001
Female	16.0	3.1	30.2	2.9	+14.2	.001

Relative survival by patient group (age or sex)	1980–1984		2000–2004		Increase*	P†
Relative survival by patient group (age or sex)	PE	SE	PE	SE	Increase*	P†
5-year
All	21.5	2.0	33.2	1.8	+11.7	< .001
15–19	41.0	4.9	61.1	4.4	+20.1	.001
20–29	25.1	4.8	44.8	4.7	+19.7	.003
30–44	20.2	4.8	34.3	3.9	+14.1	.002
45–59	10.3	4.9	24.3	3.4	+14.0	.001
≥ 60	8.4	3.4	12.7	2.9	+4.3	.48
Male	23.1	2.6	31.9	2.3	+8.8	< .001
Female	19.1	3.2	35.3	2.8	+16.2	.001
10-year
All	17.4	2.3	29.9	1.8	+12.5	< .001
15–19	33.0	4.9	60.4	4.4	+27.4	< .001
20–29	25.1	4.8	38.0	4.5	+12.9	.005
30–44	13.0	5.1	31.7	4.0	+18.7	< .001
45–59	8.4	4.4	20.2	3.4	+11.8	.001
≥ 60	5.1	3.9	9.3	2.8	+4.2	.49
Male	18.3	3.2	29.3	2.3	+11.0	< .001
Female	16.0	3.1	30.2	2.9	+14.2	.001

PE indicates point estimate; and SE, standard error.

Increase from 1980–1984 to 2000–2004 in percentage points.

P value for trend from 1980–1984 to 2000–2004.